Medical Developments International | MVP - Ordinary Share Capital


Medical Developments International reported AUD112.66M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
Clinuvel Pharmaceuticals AUD 50.2M 77.11K Dec/2025
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Genetic Signatures AUD 227.14M 0 Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Medical Developments International AUD 112.66M 2.35M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Organon & Co USD 259.98M 18K Sep/2025
Paradigm Biopharmaceuticals AUD 428.52M 39.09M Dec/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025